[{"AccountsPayableCurrent_0_Q2_USD":3798000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":24000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":12000.0,"OtherAssetsNoncurrent_0_Q2_USD":2503000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":17000.0,"OperatingIncomeLoss_2_Q2_USD":-16012000.0,"OperatingIncomeLoss_1_Q2_USD":-9850000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":420000.0,"OperatingExpenses_2_Q2_USD":16012000.0,"NonoperatingIncomeExpense_2_Q2_USD":-611000.0,"NonoperatingIncomeExpense_1_Q2_USD":12000.0,"NetIncomeLoss_2_Q2_USD":-16623000.0,"NetIncomeLoss_1_Q2_USD":-9838000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-15645000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":144232000.0,"OperatingExpenses_1_Q2_USD":9850000.0,"LiabilitiesCurrent_0_Q2_USD":5829000.0,"PrepaidExpenseCurrent_0_Q2_USD":362000.0,"ProfitLoss_2_Q2_USD":-16623000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":3095639.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":3106152.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":182680791.0,"TemporaryEquitySharesIssued_0_Q2_shares":182680791.0,"TemporaryEquitySharesAuthorized_0_Q2_shares":182680791.0,"TemporaryEquityLiquidationPreference_0_Q2_USD":187235000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_2_Q2_USD":144652000.0,"TemporaryEquityIssuePeriodIncreaseOrDecrease_2_Q2_USD":2592000.0,"StockholdersEquityNoteSubscriptionsReceivable_0_Q2_USD":284000.0,"StockholdersEquity_0_Q2_USD":-47740000.0,"ShareBasedCompensation_2_Q2_USD":790000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-48508000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":13310000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":7826000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":185413000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":143502000.0,"Liabilities_0_Q2_USD":5829000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":48000.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":0.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":128587000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":138919000.0,"Cash_0_Q2_USD":138919000.0,"AssetsCurrent_0_Q2_USD":139281000.0,"Assets_0_Q2_USD":143502000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":38287322.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":725000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":725000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1052000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":673000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":2031000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":2031000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":790000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockSharesAuthorized_0_Q2_shares":228582297.0,"CommonStockSharesIssued_0_Q2_shares":3129384.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":2503000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":285000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1823000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":2702000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":2024000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-580000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":731000.0,"EarningsPerShareDiluted_2_Q2_USD":-5.37,"EarningsPerShareDiluted_1_Q2_USD":-3.17,"EarningsPerShareBasic_2_Q2_USD":-5.37,"EarningsPerShareBasic_1_Q2_USD":-3.17,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_2_Q2_USD":0.0,"ConvertiblePreferredStockSharesIssuedUponConversion_0_Q2_shares":33942085.0,"CommonStockValue_0_Q2_USD":0.0,"CommonStockSharesOutstanding_0_Q2_shares":3129384.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":3106152.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":3095639.0,"Ticker":"NUVL","CIK":"1861560","name":"NUVALENT, INC.","OfficialName":"Nuvalent Inc. Class A Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"574936612.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210908"}]